Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Head and Neck Neoplasms 4 Prostatic Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Thyroid Nodule 1 Spinal Cord Tumor of Cervical Spine 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Pelvic Neoplasms 1 Pathologic Complete Response 1 Parotid Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Pulmonary Nodules 1 Mouth Neoplasms 1 Lymphoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Disease 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Etoposide 23 Cisplatin 15 Carboplatin 13 Irinotecan 12 apatinib 11 anlotinib 10 durvalumab 7 Topotecan 6 toripalimab 4 surufatinib 4 sintilimab 4 atezolizumab 4 Temozolomide 4 Drug Therapy 4 tislelizumab 3 lobaplatin 3 camrelizumab 3 Simvastatin 3 Radiotherapy 3 Ifosfamide 3 Albumin-Bound Paclitaxel 3 pembrolizumab 2 pegylated granulocyte colony-stimulating factor 2 olaparib 2 niraparib 2 isophosphamide mustard 2 avelumab 2 X-Rays 2 Platinum 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Small Cell Lung Carcinoma × Magnetic Resonance Imaging × Clear all

NCT04168281 2019-11-19

PCILESS

University of Warmia and Mazury in Olsztyn

Phase NA Unknown

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡